AzTrials
AzTrials

Knowledge LevelNCT05964283

Intravenous Fluid Therapy in Hospitals

An observational study of Knowledge Level and Intravenous Fluid Therapy, run by Universitas Indonesia at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The administration of intravenous fluids plays a crucial role in critically ill patients to support optimal management and ensure patient safety. Knowledge and conceptual frameworks will influence a clinician's accuracy in providing intravenous fluid therapy to patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Knowledge Level, Intravenous Fluid Therapy
What is being tested?
Questionnaire
How many people
372 participants
Where
1 siteIndonesia
Study dates
1 Aug 2023to 1 Aug 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: * Anesthesia specialists * Anesthesiologist residencies

Who may be able to join

  • All anesthesiologist residencies and are willing to complete the questionnaire.
  • All anesthesia specialists and subspecialists and are willing to complete the questionnaire until finished.

Who cannot join

  • All doctors who are unwilling and do not complete the survey questionnaire.

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Rumah Sakit Cipto Mangunkusumo

    Jakarta Pusat, DKI Jakarta, 10430

Other trials in Indonesia

About this study

Official title: Physician Knowledge Level of Intravenous Fluid Therapy in Hospitals: A Cross-Sectional Study

The administration of intravenous fluids plays a crucial role in critically ill patients to support optimal management and ensure patient safety. Knowledge and conceptual frameworks will influence a clinician's accuracy in providing intravenous fluid therapy to patients. Accurate administration of fluid therapy to patients will reduce unwanted side effects and decrease the overall treatment costs during hospitalization. Various considerations in administering intravenous fluid therapy are influenced by a clinician's level of knowledge. In Indonesia, doctors working in hospitals may have different levels of education and professional status. However, it is currently unclear whether these professional differences among doctors influence their knowledge in administering fluids to patients.

Being tested
Questionnaire

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    This questionnaire consists of (five) main parts. The first part is about personal information, the second part is about fluid administration in various settings (emergency room, operating room, and intensive care unit), the third part is about fluid administration behaviors, the fourth part is about workplace location, and the fifth part is about a case study. Filling out this questionnaire will take approximately 60 minutes of your time.

Study groups in NCT05964283
Study groupRoleWhat they receive
Anesthesia SpecialistsNot described
Receives: Other: Questionnaire
Anesthesiologist residenciesNot described
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Questionnaire regarding Physician Knowledge Level of Intravenous fluid therapy

    Intravenous Fluid Therapy knowledge Scoring

    The principle for scoring these scales is the same in all cases:

    1. Estimate the average of the items that contribute to the scale; this is the raw score. Calculating the raw score=(I1+I2+I3+…+In)/n.
    2. Use a linear transformation to standardize the raw score, so that scores range from 0 to 100; a higher score represents a higher ("better") level of knowledge. Formula use for standardization: Knowledge Score = {1-(Raw score-1)/range} X100

    The maximum score is 100 (better outcome) The minimum score is 0 (worse outcome)

    All the information related to intravenous fluid therapy is divided into five domains: (1) basic knowledge about electrolyte fluids, (2) intravenous fluid administration, (3) intravenous fluid composition, (4) fluid resuscitation, and (5) assessment of fluid volume status.

    Measured: one day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2023
  2. Study start1 Aug 2023
  3. Primary completion1 Feb 2024
  4. Study completion1 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
372 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05964283
Sponsor's protocol ID
IndonesiaUAnes047
Status last verified
May 2025
First submitted
18 Jul 2023
Last updated
2 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Malbrain MLNG, Langer T, Annane D, Gattinoni L, Elbers P, Hahn RG, De Laet I, Minini A, Wong A, Ince C, Muckart D, Mythen M, Caironi P, Van Regenmortel N. Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA). Ann Intensive Care. 2020 May 24;10(1):64. doi: 10.1186/s13613-020-00679-3.

    PubMed 32449147
  • McDougall M, Guthrie B, Doyle A, Timmins A, Bateson M, Ridley E, Drummond G, Vadiveloo T. Introducing NICE guidelines for intravenous fluid therapy into a district general hospital. BMJ Open Qual. 2022 Feb;11(1):e001636. doi: 10.1136/bmjoq-2021-001636.

    PubMed 35115322
  • Finfer S, Myburgh J, Bellomo R. Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol. 2018 Sep;14(9):541-557. doi: 10.1038/s41581-018-0044-0.

    PubMed 30072710
  • Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness: an update. Ann Intensive Care. 2016 Dec;6(1):111. doi: 10.1186/s13613-016-0216-7. Epub 2016 Nov 17.

    PubMed 27858374
  • Tommasino C. Fluids and the neurosurgical patient. Anesthesiol Clin North Am. 2002 Jun;20(2):329-46, vi. doi: 10.1016/s0889-8537(01)00013-x.

    PubMed 12165997
  • Rudloff E, Hopper K. Crystalloid and Colloid Compositions and Their Impact. Front Vet Sci. 2021 Mar 31;8:639848. doi: 10.3389/fvets.2021.639848. eCollection 2021.

    PubMed 33869319
  • Mackenzie DC, Noble VE. Assessing volume status and fluid responsiveness in the emergency department. Clin Exp Emerg Med. 2014 Dec 31;1(2):67-77. doi: 10.15441/ceem.14.040. eCollection 2014 Dec.

    PubMed 27752556

Questions about this trial

What is this clinical trial studying?

An observational study of Knowledge Level and Intravenous Fluid Therapy, run by Universitas Indonesia at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Questionnaire regarding Physician Knowledge Level of Intravenous fluid therapy (time frame: one day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05964283, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in